Business
Amylyx Pharmaceuticals to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that Joshua Cohen and Justin
About this update from Amylyx Pharmaceuticals, Inc.
[{"type":"text","content":" CAMBRIDGE, Mass.--(BUSINESS WIRE)--\nAmylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that Joshua Cohen and Justin Klee, Co-CEOs of Amylyx, will participate in the Goldman Sachs 44th Annual Global Healthcare Conference. The conference is being conducted in person in Dana Point, CA, and the fireside chat will take place on Tuesday, June 13, 2023, at 4:40pm PT/7:40pm ET.\n\n\nA live webcast of the presentation can be accessed under “Events and Presentations” in the Investor section of the Company’s website, https://investors.amylyx.com/news-events/events, and will be available for replay for 90 days following the event.\n\n\nAbout Amylyx Pharmaceuticals\n\n\nAmylyx Pharmaceuticals, Inc. is committed to supporting and creating more moments for the neurodegenerative disease community through the discovery and development of innovative new treatments. Amylyx is headquartered in Cambridge, Massachusetts and has operations in Canada and EMEA. For more information, visit amylyx.com and follow us on LinkedIn and Twitter. For investors, please visit investors.amylyx.com.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20230606005053/en/\n\nMedia\nAmylyx Media Team\n+1 (857) 799-7274\[email protected]\n\n\nInvestors\nLindsey Allen\nAmylyx Pharmaceuticals, Inc.\n+1 (857) 320-6244\[email protected]\n\n\nSource: Amylyx Pharmaceuticals, Inc.","length":4272,"tagName":"div"}]